Autres langues Sunset Capital Assets, Inc.

Actions

SNST

US86769A3059

Marché Fermé - OTC Markets Autres places de cotation 16:17:29 26/04/2024			Varia. 5j.	Varia. 1 janv.
0,0077 ^USD	+3,36%		-.--%	+26,23%

2022

Aphex BioCleanse Systems, Inc suspend le directeur Scott Smith

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Aphex BioCleanse Systems Inc Announces It Has Filed A Debtor In Possession Plan In The Florida Middle District Bankruptcy Court	15/08/22
Aphex BioCleanse Systems Inc Files for Bankruptcy Protection under Chapter 11, Subchapter V	19/05/22
Sunset Capital Assets : Year End 2021	31/03/22
Aphex BioCleanse System Inc Suspends Director Scott Smith	04/03/22
Aphex BioCleanse Systems, Inc (OTC:SNST) Suspends Director Scott Smith	18/02/22
Aphex BioCleanse Systems, Inc Suspends Director Scott Smith	18/02/22
Aphex BioCleanse Systems Engages Milestone Management Services	07/12/21
Aphex BioCleanse Systems Reports 2021 Third Quarter Operational Results	15/11/21
Quarterly Report - 3rd Quarter 2021 Financial Disclosure	11/11/21
Aphex BioCleanse Systems' Chief Sustainability Officer Scott Smith Invited to Speak at Baylor University About Sustainability Without Compromise™	04/11/21
Sunset Capital Assets : Aphex BioCleanse Systems Announces Changes in Management, Renews Focus on Regulatory Approvals and Operational Success	13/10/21
Aphex BioCleanse Systems, Inc. Announces Board and Executive Changes	13/10/21
Aphex BioCleanse Systems, Inc. Announces Resignation of Tony Fedor as Interim CEO	13/10/21
Sunset Capital Assets : Aphex BioCleanse Systems Appoints Tom Fitzgerald as Chairman of the Board; Adds Scott Buckley as New Board Member	29/09/21
Aphex BioCleanse Systems, Inc. Announces Board Appointments	29/09/21
Sunset Capital Assets : Aphex BioCleanse Systems Announces Dismissal of David J. Weaver As CEO, President, and Director	18/09/21
Sunset Capital Assets, Inc. Announces Dismissal of David J. Weaver as Ceo, President, and Director	18/09/21
Sunset Capital Assets : Aphex BioCleanse Systems Issued Patent for Sustainable, Reusable Open-Cell Foams for Disinfection of Air, Water, and Surfaces	14/09/21
Sunset Capital Assets : Aphex BioCleanse Systems' Technology Highlighted at Leading Consumer Product Show; CSO Presents Keynote on Innovative, Sustainable Personal Protective Equipment	09/09/21
Sunset Capital Assets : Aphex BioCleanse Systems Appoints Anthony Fedor as Interim CEO Focused on Scaling and Growth	27/08/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Sunset Capital Assets, Inc.

Actions

SNST

US86769A3059

Autres langues

Filtres